Up a level |
Koval, Olena and Pugach, Tetiana and Romanenko, Sergiy and Kaplan, Pavlo and Skoromna, Anastasiya (2018) Early combination therapy with Simvastatin and Fenofibrate in patients with recent acute coronary syndrome and diabetes is safe and reliably reduces lipoprotein (a) level along with other lipid indexes. Journal of the American College of Cardiology, Vol.71 (Iss.11). p. 218. ISSN 0735-1097 (Print), 1558-3597 (Electronic), 0735-1097 (Linking)